Preview this article:
Zoom in

What should be done about hepatitis-B-infected health-care workers?, Page 1 of 1

| /docserver/preview/fulltext/jmm/52/5/JMM5205.371-1.gif

There is no abstract available for this article.
Use the preview function to the left.


Article metrics loading...

Loading full text...

Full text loading...



  1. Carman, W. F., Jacyna, M. R., Hadziyannis, S., Karayiannis, P., McGarvey, M. J., Makris, A. & Thomas, H. C. ( 1989;). Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet ii , 588–591.
    [Google Scholar]
  2. Department of Health ( 1993;). Protecting health care workers and patients from hepatitis B. Health Service Guidelines HSG (93) 40. London: Department of Health.
  3. Department of Health ( 1998;). Guidance for clinical health care workers: protection against infection with blood-borne viruses. Health Service Circular HSC (1998)/063. London: Department of Health.
  4. Department of Health ( 2000;). Hepatitis B infected health care workers. Health Service Circular HSC (2000)/02. London: Department of Health.
  5. Hadziyannis, S. J., Tassopoulos, N. C., Heathcote, E. J. & 10 other authors ( 2003;). Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med Med 348, 800–807.[CrossRef]
    [Google Scholar]
  6. Heptonstall, J., Barnes, J., Burton, E. & 25 other authors ( 1997;). Transmission of hepatitis B from four infected surgeons without hepatitis B e antigen.The Incident Investigation Teams and others. N Engl J Med 336, 178–184.[CrossRef]
    [Google Scholar]
  7. Lai, C. L., Chien, R. N. & Leung, N. W. & 9 other authors ( 1998;). A one-year trial of lamivudine for chronic hepatitis B.Asia Hepatitis Lamivudine Study Group. N Engl J Med 339, 61–68.[CrossRef]
    [Google Scholar]
  8. Liaw, Y.-F. ( 2002;). Therapy of chronic hepatitis B: current challenges and opportunities. J Viral Hepat 9, 393–399.[CrossRef]
    [Google Scholar]
  9. Liaw, Y.-F., Leung, N. W. Y., Chang, T. T. & 8 other authors ( 2000;). Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B.Asia Hepatitis Lamivudine Study Group. Gastroenterology 119, 172–180.[CrossRef]
    [Google Scholar]
  10. Lindh, M., Horal, P., Dhillon, A. P. & Norkrans, G. ( 2000;). Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat 7, 258–267.[CrossRef]
    [Google Scholar]
  11. Martinot-Peignoux, M., Boyer, N., Colombat, M. & 7 other authors ( 2002;). Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 36, 543–546.[CrossRef]
    [Google Scholar]
  12. Melegari, M., Scaglioni, P. P. & Wands, J. R. ( 1998;). Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology 27, 628–633.[CrossRef]
    [Google Scholar]
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error